$ICDIQ
Independence Contract Drilling, Inc.

2021 Q4 Form 10-K Financial Statement

#000153702822000007 Filed on March 15, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $28.56M $87.96M $13.32M
YoY Change 114.44% 5.44% -70.59%
Cost Of Revenue $24.05M $75.75M $12.38M
YoY Change 94.24% 15.83% -63.46%
Gross Profit $4.514M $12.20M $940.0K
YoY Change 380.21% -32.57% -91.76%
Gross Profit Margin 15.8% 13.88% 7.06%
Selling, General & Admin $3.870M $15.70M $3.380M
YoY Change 14.5% 16.43% -28.69%
% of Gross Profit 85.73% 128.64% 359.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.671M $38.90M $10.58M
YoY Change -8.59% -11.39% -8.24%
% of Gross Profit 214.24% 318.75% 1125.53%
Operating Expenses $13.69M $15.70M $13.96M
YoY Change -1.93% 16.43% -16.16%
Operating Profit -$9.177M -$43.12M -$39.34M
YoY Change -76.67% -47.52% 22.11%
Interest Expense -$3.899M -$15.19M -$3.820M
YoY Change 2.07% 3.87% 9.14%
% of Operating Profit
Other Income/Expense, Net -$150.0K
YoY Change
Pretax Income -$13.04M -$48.18M -$43.16M
YoY Change -69.79% -50.22% 20.83%
Income Tax $18.45M $18.53M -$63.00K
% Of Pretax Income
Net Earnings -$31.48M -$66.71M -$43.10M
YoY Change -26.94% -30.97% 23.1%
Net Earnings / Revenue -110.23% -75.85% -323.57%
Basic Earnings Per Share -$8.89
Diluted Earnings Per Share -$3.224M -$8.89 -$7.020M
COMMON SHARES
Basic Shares Outstanding 9.563M 7.507M 6.176M shares
Diluted Shares Outstanding 7.507M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.140M $4.140M $12.30M
YoY Change -66.34% -66.34% 136.54%
Cash & Equivalents $4.140M $4.140M $12.28M
Short-Term Investments
Other Short-Term Assets $9.000K $4.787M $4.000K
YoY Change 125.0% 16.76% -99.63%
Inventory $1.171M $1.171M $1.000M
Prepaid Expenses
Receivables $22.21M $22.21M $10.02M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $32.31M $32.31M $27.44M
YoY Change 17.74% 17.92% -51.64%
LONG-TERM ASSETS
Property, Plant & Equipment $363.8M $363.8M $382.2M
YoY Change -4.83% -5.36% -16.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.449M $1.012M $3.528M
YoY Change -30.58% -27.71% 29.42%
Total Long-Term Assets $364.8M $364.8M $385.8M
YoY Change -5.44% -5.44% -16.18%
TOTAL ASSETS
Total Short-Term Assets $32.31M $32.31M $27.44M
Total Long-Term Assets $364.8M $364.8M $385.8M
Total Assets $397.1M $397.1M $413.2M
YoY Change -3.9% -3.9% -20.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.30M $15.30M $4.072M
YoY Change 275.83% 273.27% -82.04%
Accrued Expenses $11.25M $11.81M $10.72M
YoY Change 4.87% 44.06% -34.49%
Deferred Revenue $542.0K $119.0K
YoY Change 355.46% -83.02%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $4.464M $4.286M
YoY Change -100.0% -41.26%
Total Short-Term Liabilities $38.29M $38.29M $22.43M
YoY Change 70.68% 70.92% -53.81%
LONG-TERM LIABILITIES
Long-Term Debt $141.7M $141.7M $137.6M
YoY Change 3.01% 3.01% 2.0%
Other Long-Term Liabilities $2.811M $2.811M $2.704M
YoY Change 3.96% -49.8% 116.49%
Total Long-Term Liabilities $2.811M $144.6M $2.704M
YoY Change 3.96% 0.94% 116.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $38.29M $38.29M $22.43M
Total Long-Term Liabilities $2.811M $144.6M $2.704M
Total Liabilities $201.9M $201.9M $166.2M
YoY Change 21.48% 21.47% -10.37%
SHAREHOLDERS EQUITY
Retained Earnings -$333.8M -$267.1M
YoY Change 24.98% 56.7%
Common Stock $532.9M $518.0M
YoY Change 2.88% 2.4%
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.923M $3.913M
YoY Change 0.26% 1.72%
Treasury Stock Shares $81.85K $78.58K
Shareholders Equity $195.2M $195.2M $247.0M
YoY Change
Total Liabilities & Shareholders Equity $397.1M $397.1M $413.2M
YoY Change -3.9% -3.9% -20.08%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$31.48M -$66.71M -$43.10M
YoY Change -26.94% -30.97% 23.1%
Depreciation, Depletion And Amortization $9.671M $38.90M $10.58M
YoY Change -8.59% -11.39% -8.24%
Cash From Operating Activities -$1.876M -$9.579M -$6.800M
YoY Change -72.41% -3437.63% -1006.67%
INVESTING ACTIVITIES
Capital Expenditures -$6.723M $16.42M -$1.540M
YoY Change 336.56% 15.36% -54.03%
Acquisitions
YoY Change
Other Investing Activities $188.0K $2.037M $2.660M
YoY Change -92.93% -61.2% 133.33%
Cash From Investing Activities -$6.535M -$14.38M $1.120M
YoY Change -683.48% 60.16% -150.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.249M 15.82M -850.0K
YoY Change -1070.47% 0.35% -65.86%
NET CHANGE
Cash From Operating Activities -1.876M -9.579M -6.800M
Cash From Investing Activities -6.535M -14.38M 1.120M
Cash From Financing Activities 8.249M 15.82M -850.0K
Net Change In Cash -162.0K -8.139M -6.530M
YoY Change -97.52% -215.07% 65.74%
FREE CASH FLOW
Cash From Operating Activities -$1.876M -$9.579M -$6.800M
Capital Expenditures -$6.723M $16.42M -$1.540M
Free Cash Flow $4.847M -$25.99M -$5.260M
YoY Change -192.15% 86.44% -228.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7507000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4907000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3774000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2021Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2021Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-8.89
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-19.69
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-16.11
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001537028
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2020Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2021Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.05
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-8.89
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-19.69
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-16.11
CY2020Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.05
CY2020Q2 icd Debt Instrument Accrued And Unpaid Interest Only Payment Period
DebtInstrumentAccruedAndUnpaidInterestOnlyPaymentPeriod
P3M
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2020Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2020Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2020Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2020Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2020Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations
CY2020Q2 icd Debt Instrument Accrued And Unpaid Interest Only Payment Period
DebtInstrumentAccruedAndUnpaidInterestOnlyPaymentPeriod
P3M
CY2020Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.05
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-36590
CY2021 dei Entity Registrant Name
EntityRegistrantName
INDEPENDENCE CONTRACT DRILLING, INC.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1653648
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
20475 State Highway 249
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77070
CY2021 dei City Area Code
CityAreaCode
281
CY2021 dei Local Phone Number
LocalPhoneNumber
598-1230
CY2021 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
CY2021 dei Trading Symbol
TradingSymbol
ICD
CY2021 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
25264376
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11349005
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15617000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10723000
CY2021 dei Auditor Firm
AuditorFirmId
243
CY2021 dei Auditor Name
AuditorName
BDO USA, LLP
CY2021 dei Auditor Location
AuditorLocation
Houston, Texas
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4140000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12279000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
500000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22211000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10023000
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1171000
CY2020Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1038000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4787000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4102000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
32309000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
27442000
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
362346000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
382239000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2449000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3528000
CY2021Q4 us-gaap Assets
Assets
397104000
CY2020Q4 us-gaap Assets
Assets
413209000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
4464000
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
7637000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
15304000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4072000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
2902000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
38287000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22432000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
141740000
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
137633000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
2902000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
19037000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
505000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2811000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2704000
CY2021Q4 us-gaap Liabilities
Liabilities
201875000
CY2020Q4 us-gaap Liabilities
Liabilities
166176000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10287931
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6175818
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
102000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6254396
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10206085
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
62000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
532826000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
517948000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-333776000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-267064000
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
245000
CY2020 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-723000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
81846
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
78578
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3923000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3913000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
195229000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
247033000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
397104000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
413209000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87955000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83418000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
203602000
CY2021 us-gaap Direct Operating Costs
DirectOperatingCosts
75751000
CY2020 us-gaap Direct Operating Costs
DirectOperatingCosts
65367000
CY2019 us-gaap Direct Operating Costs
DirectOperatingCosts
144913000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15699000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13484000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16051000
CY2020 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1076000
CY2019 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2698000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
38915000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
43919000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
45367000
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
800000
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
41007000
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
35748000
CY2019 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-4943000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-150000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-377000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
131070000
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
165576000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
250097000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-43115000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-82158000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-46495000
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-15193000
CY2020 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-14627000
CY2019 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-14415000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
10128000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48180000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-96785000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-60910000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18532000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-147000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-122000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-66712000
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-19.69
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-96638000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-60788000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-8.89
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-16.11
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7507000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4907000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3774000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
391533000
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2019 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
-34000
CY2019 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
809000
CY2019 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
177000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1871000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-60788000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
331596000
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0
CY2020 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
-44000
CY2020 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
66000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10206000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1979000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-96638000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
247033000
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
-14000
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8969000
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
4239000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1724000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-66712000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
195229000
CY2021 us-gaap Profit Loss
ProfitLoss
-66712000
CY2020 us-gaap Profit Loss
ProfitLoss
-96638000
CY2019 us-gaap Profit Loss
ProfitLoss
-60788000
CY2021 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
38915000
CY2020 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
43919000
CY2019 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
45367000
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
800000
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
41007000
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
35748000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2295000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
1979000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
1871000
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
245000
CY2020 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-723000
CY2019 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-4943000
CY2021 us-gaap Paid In Kind Interest
PaidInKindInterest
5883000
CY2020 us-gaap Paid In Kind Interest
PaidInKindInterest
0
CY2019 us-gaap Paid In Kind Interest
PaidInKindInterest
0
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
18532000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
10128000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-147000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-122000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1115000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
988000
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
814000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-52000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
16000
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
459000
CY2021 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
12136000
CY2020 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-26026000
CY2019 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-5695000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
133000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-117000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
349000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-57000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1023000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1473000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12230000
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-16680000
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7190000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9579000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
287000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27921000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16415000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14229000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38320000
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2037000
CY2020 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5107000
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
8951000
CY2021 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0
CY2020 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0
CY2019 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
1000000
CY2021 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
0
CY2020 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
145000
CY2019 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
0
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14378000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8977000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28369000
CY2021 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
6309000
CY2020 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
11045000
CY2019 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
4511000
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
17000
CY2020 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
11038000
CY2019 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
7077000
CY2021 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0
CY2020 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
10000000
CY2019 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2019 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
177000
CY2021 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
10000
CY2020 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
66000
CY2019 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
809000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
14000
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
44000
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
34000
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
3594000
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
4340000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2980000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15818000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15763000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6593000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8139000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7073000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7041000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12279000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5206000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12247000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4140000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12279000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5206000
CY2022Q1 icd Market Price Of Oil
MarketPriceOfOil
96.13
CY2022Q1 icd Natural Gas Price
NaturalGasPrice
6.70
CY2021Q4 icd Number Of Rigs Under Operating
NumberOfRigsUnderOperating
16
CY2021Q4 icd Number Of Rigs Under Contract
NumberOfRigsUnderContract
17
CY2020 icd Social Security Tax Employer Deferral Cares Act
SocialSecurityTaxEmployerDeferralCARESAct
800000
CY2022Q1 icd Social Security Tax Employer Payment Cares Act
SocialSecurityTaxEmployerPaymentCaresAct
400000
CY2020Q2 us-gaap Line Of Credit Facility Commitment Fee Percentage
LineOfCreditFacilityCommitmentFeePercentage
0.0075
CY2021Q4 us-gaap Paid In Kind Interest
PaidInKindInterest
3100000
CY2022Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
3200000
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 icd Sale Of Stock Maximum Aggregate Offering Price Value
SaleOfStockMaximumAggregateOfferingPriceValue
11000000.0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11000000.0
CY2021Q1 icd Sale Of Stock Maximum Aggregate Offering Price Additional Value
SaleOfStockMaximumAggregateOfferingPriceAdditionalValue
2200000
CY2021Q3 icd Sale Of Stock Maximum Aggregate Offering Price Additional Value
SaleOfStockMaximumAggregateOfferingPriceAdditionalValue
7500000
CY2021Q4 icd Sale Of Stock Maximum Aggregate Offering Price Additional Value
SaleOfStockMaximumAggregateOfferingPriceAdditionalValue
5900000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
77523973
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76241045
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3876196
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3812050
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q2 icd Due To Related Parties Deferred Payment
DueToRelatedPartiesDeferredPayment
2900000
icd Deferred Payment Interest Accrual Rate
DeferredPaymentInterestAccrualRate
0.15
CY2021Q1 icd Deferred Payment Interest Accrual Rate
DeferredPaymentInterestAccrualRate
0.25
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1200000
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
300000
CY2020Q1 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
3300000
CY2020Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
13300000
CY2020Q4 icd Number Of Rigs Removed
NumberOfRigsRemoved
5
CY2020Q4 icd Number Of Rigs Removed
NumberOfRigsRemoved
5
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
500000
CY2021Q4 icd Number Of Field Locations
NumberOfFieldLocations
5
CY2020 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0
CY2021 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0
CY2019 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
300000
CY2021 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
2600000
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
119000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the balance sheet date, and the reported amounts of revenues and expenses recognized during the reporting period. Actual results could differ from these estimates. Significant estimates made by management include depreciation of property, plant and equipment, impairment of property, plant and equipment and assets held for sale, and the collectability of accounts receivable.</p>
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87955000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83418000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
203602000
CY2020Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
0
CY2021Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
0
CY2021Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
22167000
CY2020Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
9772000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
542000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
119000
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
311000
CY2021 icd Contract With Customer Liability Increase Decrease From Cash Receipts
ContractWithCustomerLiabilityIncreaseDecreaseFromCashReceipts
542000
CY2020 icd Contract With Customer Liability Increase Decrease From Cash Receipts
ContractWithCustomerLiabilityIncreaseDecreaseFromCashReceipts
119000
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
542000
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
542000
CY2021Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
600000
CY2020Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
100000
CY2021 icd Capitalized Contract Cost Increase
CapitalizedContractCostIncrease
3100000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1729000
CY2021Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M18D
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1729000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2693000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
928000
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
616000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
3033000
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2863000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
431000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
382000
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1158000
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1257000
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
585000
CY2020 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
806000
CY2021 icd Finance Lease Cost
FinanceLeaseCost
1743000
CY2020 icd Finance Lease Cost
FinanceLeaseCost
2063000
CY2021 us-gaap Lease Cost
LeaseCost
6135000
CY2020 us-gaap Lease Cost
LeaseCost
5924000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
964000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
634000
CY2021 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
580000
CY2020 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
798000
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
3594000
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
4340000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1601000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
1503000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
2648000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1437000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2150000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
693000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
964000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1036000
CY2021Q4 icd Finance Lease Right Of Use Asset Gross
FinanceLeaseRightOfUseAssetGross
14989000
CY2020Q4 icd Finance Lease Right Of Use Asset Gross
FinanceLeaseRightOfUseAssetGross
13700000
CY2021Q4 icd Finance Lease Right Of Use Asset Accumulated Depreciation
FinanceLeaseRightOfUseAssetAccumulatedDepreciation
1989000
CY2020Q4 icd Finance Lease Right Of Use Asset Accumulated Depreciation
FinanceLeaseRightOfUseAssetAccumulatedDepreciation
981000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
13000000
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
12719000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
4464000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
3351000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1305000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
4570000
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
5769000
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
7921000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M12D
CY2020Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1084
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0825
CY2021Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0864
CY2020Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0888
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
840000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
4868000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
760000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1068000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
372000
CY2021Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
200000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
0
CY2021Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
0
CY2021Q4 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
0
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0
CY2021Q4 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
0
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1972000
CY2021Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
6136000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
243000
CY2021Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
367000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1729000
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
5769000
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1171000
CY2020Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1038000
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2019 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2020 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2021 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
580427000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
564778000
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
218081000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
182539000
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
362346000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
382239000
CY2021 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
13400000
CY2020 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
9700000
CY2019 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
27200000
CY2021 us-gaap Depreciation
Depreciation
38900000
CY2020 us-gaap Depreciation
Depreciation
43900000
CY2019 us-gaap Depreciation
Depreciation
45400000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
3463000
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
3346000
CY2021 icd Purchases Of Property Plant And Equipment In Accounts Payable
PurchasesOfPropertyPlantAndEquipmentInAccountsPayable
3564000
CY2020 icd Purchases Of Property Plant And Equipment In Accounts Payable
PurchasesOfPropertyPlantAndEquipmentInAccountsPayable
-7201000
CY2019 icd Purchases Of Property Plant And Equipment In Accounts Payable
PurchasesOfPropertyPlantAndEquipmentInAccountsPayable
1607000
CY2020 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
2650000
CY2019 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
13143000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
575000
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
636000
CY2021Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
618000
CY2021 icd Transfer Of Assets From Held And Used To Held For Sale
TransferOfAssetsFromHeldAndUsedToHeldForSale
1082000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15617000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10723000
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2166000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
4372000
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
3573000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
693000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
964000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
739000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
302000
CY2020Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
89000
CY2021Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
122000
CY2020Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
27000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
9000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4787000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4102000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4154000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1472000
CY2021Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
2523000
CY2020Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
2127000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
542000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
119000
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2594000
CY2021 us-gaap Interest Paid
InterestPaid
6918000
CY2020 us-gaap Interest Paid
InterestPaid
13309000
CY2019 us-gaap Interest Paid
InterestPaid
13974000
CY2020 icd Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost And Other Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCostAndOtherAmount
351000
CY2021 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1503000
CY2020 icd Transfer Of Assets From Held And Used To Held For Sale
TransferOfAssetsFromHeldAndUsedToHeldForSale
0
CY2019 icd Transfer Of Assets From Held And Used To Held For Sale
TransferOfAssetsFromHeldAndUsedToHeldForSale
18506000
CY2021 icd Transfer Of Assets From Inventory To Fixed Assets
TransferOfAssetsFromInventoryToFixedAssets
0
CY2020 icd Transfer Of Assets From Inventory To Fixed Assets
TransferOfAssetsFromInventoryToFixedAssets
0
CY2019 icd Transfer Of Assets From Inventory To Fixed Assets
TransferOfAssetsFromInventoryToFixedAssets
406000
CY2021 icd Finance Lease Extinguishment Of Lease Obligations From Sale Of Assets
FinanceLeaseExtinguishmentOfLeaseObligationsFromSaleOfAssets
65000
CY2020 icd Finance Lease Extinguishment Of Lease Obligations From Sale Of Assets
FinanceLeaseExtinguishmentOfLeaseObligationsFromSaleOfAssets
1549000
CY2019 icd Finance Lease Extinguishment Of Lease Obligations From Sale Of Assets
FinanceLeaseExtinguishmentOfLeaseObligationsFromSaleOfAssets
249000
CY2021 icd Gain Loss On Extinguishment Of Debt Excluding Interest
GainLossOnExtinguishmentOfDebtExcludingInterest
10000000
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
5769000
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
7921000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
147952000
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
147929000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4286000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
4464000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
3351000
CY2021Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
1748000
CY2020Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
2659000
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
141740000
CY2020Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
137633000
CY2021Q4 icd Long Term Debt Gross Maturity Year One
LongTermDebtGrossMaturityYearOne
0
CY2021Q4 icd Long Term Debt Gross Maturity Year Two
LongTermDebtGrossMaturityYearTwo
142183000
CY2021Q4 icd Long Term Debt Gross Maturity Year Three
LongTermDebtGrossMaturityYearThree
0
CY2021Q4 icd Long Term Debt Gross Maturity After Year Three
LongTermDebtGrossMaturityAfterYearThree
0
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
142183000
CY2020Q2 us-gaap Line Of Credit Facility Commitment Fee Percentage
LineOfCreditFacilityCommitmentFeePercentage
0.0075
CY2020Q2 icd Debt Instrument Direct Reduction From Face Amount
DebtInstrumentDirectReductionFromFaceAmount
1000000.0
CY2019 icd Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost And Other Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCostAndOtherAmount
79000
CY2021Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
315000
CY2020Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
738000
CY2021Q2 us-gaap Paid In Kind Interest
PaidInKindInterest
2800000
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
194000
CY2021 icd Effective Income Tax Rate Reconciliation Loan Forgiveness
EffectiveIncomeTaxRateReconciliationLoanForgiveness
-2127000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18532000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-147000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-122000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
29268000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
19800000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
12626000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
882000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-116000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-396000
CY2021 icd Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost And Other Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCostAndOtherAmount
490000
CY2021Q4 us-gaap Paid In Kind Interest
PaidInKindInterest
3100000
CY2022Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
3200000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
17417000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
1115000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-147000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-122000
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-10128000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-20285000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-12791000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
147000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
103000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
360000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18532000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-147000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-122000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.385
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.002
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.002
CY2021Q4 icd Deferred Tax Assets Merger Related Expenses
DeferredTaxAssetsMergerRelatedExpenses
960000
CY2020Q4 icd Deferred Tax Assets Merger Related Expenses
DeferredTaxAssetsMergerRelatedExpenses
1130000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
119000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1247000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1168000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
292000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
44000
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
119000
CY2020Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
28000
CY2021Q4 icd Deferred Tax Assets Interest Limitation
DeferredTaxAssetsInterestLimitation
3281000
CY2020Q4 icd Deferred Tax Assets Interest Limitation
DeferredTaxAssetsInterestLimitation
3298000
CY2021Q4 icd Deferred Tax Asset Right Of Use Asset
DeferredTaxAssetRightOfUseAsset
379000
CY2020Q4 icd Deferred Tax Asset Right Of Use Asset
DeferredTaxAssetRightOfUseAsset
769000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
93733000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
79373000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
100011000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
85929000
CY2021Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
740000
CY2020Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
769000
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
38000000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
35086000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
39055000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
36787000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
79993000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
49647000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
19037000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
505000
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
432500000
CY2021Q4 icd Operating Loss Carryforwards Subject To Expiration
OperatingLossCarryforwardsSubjectToExpiration
131100000
CY2021Q4 icd Operating Loss Carryforwards Not Subject To Expiration
OperatingLossCarryforwardsNotSubjectToExpiration
301400000
CY2021 icd Operating Loss Carryforwards Expiration Amount
OperatingLossCarryforwardsExpirationAmount
81200000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
254.80
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
254.80
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
27867
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
254.80
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
27867
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
254.80
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
27867
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P0Y1M28D
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2295000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1979000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1871000
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
33458
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
254.80
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
5591
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0186
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0138
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3774000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3774000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7507000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4907000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
81846
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-66712000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-96638000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-60788000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-8.89
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-19.69
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-16.11
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7507000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4907000
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2021 us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
2900000
CY2021 us-gaap Payments For Deposits
PaymentsForDeposits
200000
CY2021Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
200000
CY2021Q4 icd Employment Agreement Number Of Employees
EmploymentAgreementNumberOfEmployees
6
CY2021 icd Employment Agreement Term
EmploymentAgreementTerm
P3Y
CY2021Q4 icd Employment Agreement Minimum Annual Cash Compensation
EmploymentAgreementMinimumAnnualCashCompensation
1900000
CY2021Q4 icd Employment Agreement Severance Clause Amount
EmploymentAgreementSeveranceClauseAmount
4900000
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
3800000
CY2021Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
2900000
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1200000

Files In Submission

Name View Source Status
0001537028-22-000007-index-headers.html Edgar Link pending
0001537028-22-000007-index.html Edgar Link pending
0001537028-22-000007.txt Edgar Link pending
0001537028-22-000007-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
icd-20211231.xsd Edgar Link pending
icd-20211231ex103eef636.htm Edgar Link pending
icd-20211231ex2314635e6.htm Edgar Link pending
icd-20211231ex311bffba9.htm Edgar Link pending
icd-20211231ex3122d0f55.htm Edgar Link pending
icd-20211231ex32156acaf.htm Edgar Link pending
icd-20211231x10k.htm Edgar Link pending
icd-20211231x10k001.jpg Edgar Link pending
icd-20211231x10k_htm.xml Edgar Link completed
icd-20211231_cal.xml Edgar Link unprocessable
icd-20211231_def.xml Edgar Link unprocessable
icd-20211231_lab.xml Edgar Link unprocessable
icd-20211231_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending